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Abstract
Background: Inadequate funding for vaginal delivery can be
one of the barriers to reducing the maternal mortality rate. It could
be therefore critical to compare the vaginal delivery cost between
total hospital cost and INA-CBGs cost in national health insur-
ance. 
Methods: This was a retrospective cross-sectional study con-
ducted from October to December 2019 in Universitas Airlangga
Academic Hospital. It collected data on primary diagnosis, length
of stay, total hospital cost, INA-CBGs cost, and counted disparity.
The data analyzed statistically using t-test independent sample (or
Mann-Whitney test). 
Results: A total of 149 vaginal delivery claims were found,
with the majority having a level II severity (79.87%) and moderate
preeclampsia as a primary diagnosis (20.1%). There was a signif-
icant disparity in higher total hospital costs compared with gov-
ernment INA-CBGs costs (Rp. 9,238,022.09±1,265,801.88 vs
1,881,521.48±12,830.15; p<0.001). There was also an increase of
LOS (p<0.001), total hospital cost (p<0.001), and cost disparity
(p<0.01) in a higher severity level of vaginal delivery. 
Conclusion: Vaginal delivery costs in INA-CBGs scheme are
underneath the actuarial value. There was also an increase in total
hospital costs and a more significant disparity in the higher sever-
ity levels of vaginal delivery.
Introduction
One of the most significant problems in the Indonesian health
sector is the implementation of the national health insurance sys-
tem (JKN). This aims to achieve universal health insurance so that
all citizens benefit from health services and protection in meeting
primary health needs. As one of the systems declared by the state
with law number 40/2004, this system has been running since
2014.1 One of the fundamental changes in the payment system to
hospitals is from a retrospective payment (service fee) model to a
prospective payment system or bundling known as Indonesia Case
Base Groups (INA-CBGs).2,3 The number of claims or bundling is
significant to be adjusted with actuarial value in order to ensure
adequate quality of health services.
In maternal health services, JKN influences the management
of maternal patient management in health facilities. Another
important consideration is the situation of the Maternal Mortality
Rate (MMR) in Indonesia, which is still high, which is around
305/100,000 live births.4 Meanwhile, the World Health
Organization (WHO) has set a global target for maternal mortality,
which is no more than 70/100,000 live births by 2030.5 JKN is
expected to support the elimination of causes of maternal death
known as “three delays”. This consists of: delays in recognizing
signs of danger, delays in achieving proper health care and delays
in receiving adequate care remain primary considerations for
improvement.6,7
The insufficient availability of funds for delivery can be one
of the administrative obstacles that are directly or indirectly relat-
ed to efforts to reduce maternal mortality. From the above back-
ground, this study aims to compare the cost of claims for INA-
CBGs in hospitals with the actual cost of vaginal delivery as the
largest proportion of delivery mode nationally (81.5%).8 At the
same time, the adequacy of this financing is predicted to be close-
ly related to the quality of delivery services in Indonesia by using
national health insurance.
Methods
The study used a cross-sectional design by utilizing data on
total hospital costs and INA-CBGs claims. It was taken from
October to December 2019 at Airlangga University Academic
Hospital (RSUA), Surabaya East Java Indonesia. 
All claims data related to vaginal delivery were selected and
included in our study. Additionally, to eliminate bias from the
study, the authors included only single pregnancies because of the
more significant costs associated with caring for more than one
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Significance for public health
The inadequate availability of funds for childbirth can be one of the administrative constraints that are directly or indirectly related to efforts to reduce mater-
nal mortality. This study will give references to government, stakeholder, and researchers to highlight the urgency of vaginal delivery cost in a country.
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baby if the mother had multiple pregnancies. We also excluded
cases of severe preterm preeclampsia that required conservative
care before delivery to prolong the period of hospitalization and
increase the total cost. In the INA-CBGs classification, delivery is
included in the Case-Mix Main Groups (CMG): O (Deliveries
group). Then in the current INA-CBG grouping, vaginal delivery
whose complexity is divided into vaginal delivery (CMG: O-6-13),
vaginal delivery with procedures other than sterilization/dilation/
and curettage (CMG: O-6-12), and vaginal delivery discharge with
sterilization/dilation/ and curettage (CMG: O-6-11). All severity
levels (level I to level III) for each type of vaginal delivery group
were included in this study and will be stratified for analysis.
Data collected from each claim case includes the primary diag-
nosis, length of stay, total hospital cost, INA-CBGs cost and count-
ed cost disparity (INA-CBGs cost - total hospital cost) and will be
grouped into severity levels in the vaginal delivery of INA-CBGs
group. The rates of INA-CBGs taken here are adjusted to the clas-
sification of Airlangga University Academic Hospital, which is
inpatient cases in Regional 1 area (East Java), government, and
class B Hospitals which has been regulated based on the minister
of health regulation number 64/2016.9 The categorical variables
are shown in terms of frequency and percentage (%), while contin-
uous variables were reported using the mean ± standard deviance
(SD). The T-Test independent sample (or Mann-Whitney test) was
used to compare the difference in the continuous variables between
groups. Paired samples t-test or Wilcoxon signed-rank test were
also used to compare cost disparity in all samples. All statistical
analyses were performed using the SPSS software package (IBM
Corp., Armonk NY, USA) version 24.0. A p-value of <0.05 was
taken to signify statistical significance.
Results
Primary diagnosis, severity levels, and total claims of
vaginal delivery
For three months, we found a total of 149 vaginal delivery
claims were included in the study. The majority of cases had level
II severity based on INA-CBGs group (119 cases, 79.87%). The
general primary diagnosis for vaginal delivery at the Airlangga
University Academic Hospital includes a diagnosis of moderate
pre-eclampsia (30 cases, 20.1%), the prolonged first stage of
labour (24 cases, 16.1%), premature rupture of membrane, and
excessive weight gain in pregnancy respectively 21 cases (14.1%).
For severity level I, in vaginal delivery, most cases that came to the
hospital were caused by the prolonged first stage of labour (23/30
cases, 76.7%). Meanwhile, at severity level II, the highest diagno-
sis was moderate pre-eclampsia (30/119 cases, 25.2%). The data
distribution of the primary diagnosis is reported in Figure 1.
INA-CBGs claim for vaginal delivery
For the INA-CBG group in all cases of vaginal delivery includ-
ed in this study, only two types of complexity were found: vaginal
delivery (CMG: O-6-13) and vaginal delivery other than steriliza-
tion/dilatation/and curettage procedures (CMG: O-6-12) group
with only two levels of severity. Table 1 illustrated the claims of
INA-CBGs for each group at Airlangga University Academic
Hospital (Regional 1 area, government, and class B Hospitals),
based on the regulation of the Indonesian Ministry of Health.7
Comparison of total hospital costs and INA-CBGs cost
in vaginal delivery
By comparing the bundling price for vaginal delivery that has
been determined by the government in the INA-CBGs, it has been
found that the total hospital cost is significantly greater than the
price determined by the government through the INA-CBGs
(p<0.001) (Table 2).
Analysis of severity level in vaginal delivery
There was also a significant increase in the length of the stay
(LOS) (p<0.001), total hospital cost (p<0.001) and cost disparity
between INA-CBGs determined by the government and total hos-
pital costs (p<0.01) in this study (Table 3).
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Table 1. INA-CBGs claim for vaginal delivery.
INA-CBGs code            INA-CBGs description                                                                                                                              Class 3 claim
O-6-13-I                                  Vaginal delivery (severity level I)                                                                                                                                                        Rp 1,626,200
O-6-13-II                                 Vaginal delivery (severity level II)                                                                                                                                                       Rp 1,924,700
O-6-12-I                                  Vaginal delivery with procedures other than sterilization and/dilatation and curettage (severity level I)                       Rp 2,436,200
O-6-12-II                                 Vaginal delivery with procedures other than sterilization and/dilatation and curettage (severity level II)                      Rp 2,925,200
Figure 1. Distribution of primary diagnosis, severity levels, and











The implementation of the National Health Insurance (JKN) in
Indonesia from 2014 has changed various financing systems in
health facilities. In terms of JKN’s participants or users, this pro-
gram provides an advantage because access to health facilities can
be obtained at an affordable price of about Rp. 42,000 (USD 2.83)
per month for the lowest class according to the latest presidential
regulation.10,11 It can be shown through an increased number of
participants. It started from 133,423,653 residents in 2014 to
224,149,019 residents (83.86% of the total population in
Indonesia) in 2019 who are registered as JKN’s participants. Also,
the number of the referred hospital, which collaborates with this
program rise every year (46.28% from 2014 to 2019).12
This study focused on national health insurance in vaginal
delivery services. The results of this study showed that the main
diagnosis of vaginal delivery in Airlangga University Academic
Hospital is predominantly due to preeclampsia, the primary diag-
nosis for both overall and severity level 2 vaginal delivery is mod-
erate preeclampsia. Meanwhile, dystocia disorders in the pro-
longed first stage of labour dominate vaginal delivery with severity
level 1. Several reports in Indonesia showed a high prevalence of
preeclampsia up to around 12.7 compared to reports in developed
countries such as in the US (8.34%).13 This is in line with
Wardhana’s findings study, which showed a very high prevalence
of preeclampsia, with up to 1106 cases (21%) in 2 years in a refer-
ral teaching hospital in Surabaya.14 Indeed, this affects preeclamp-
sia referrals where labour and delivery cannot be done in primary
healthcare, which is not adequate resources to handle cases.11,15
Delivery services are essential health services in human life,
although specific diseases do not always follow them and often
result in significant health financing.14 Delivery services also had
the highest cost of all episodes of maternal care.16,17 The main
issue of this study is that the government’s claim for vaginal deliv-
ery through the INA-CBGs group is significantly lower than the
total costs incurred by the hospital. The higher the severity of vagi-
nal delivery, the higher the disparity and increase in the length of
stay (LOS) so that the hospital financing package will increase.
There has never been a study comparing the costs of vaginal deliv-
ery, particularly in Indonesia. However, this study shows low
claims of funding from the Indonesian government for vaginal
delivery. Claims for vaginal delivery cost with the lowest complex-
ity based on the hospital classification where the study was con-
ducted were Rp. 1,626,200 or if converted around USD 109.49.9
In other hands, some observations from the Independent
Hospital Pricing Authority report in Australia show that a single
vaginal delivery episode with DRG O60C - ‘vaginal delivery,
minor complexity’ has a higher claim of about 34 times (AUD
4,777 or USD 3,422) than vaginal delivery cost claims in
Indonesia.18,19 A report from the US also states that Medicaid
financing using a blended payment in Minnesota in 2009 gave a
price of USD 3144 to 3528 USD.20 Another study from Bellanger
of 11 European countries, shows claims that vary widely different.
For cases of vaginal delivery with one day LOS, the lowest DRG
claim prices were found in Poland (479 Euros ~ 561 USD) up to
2047 Euros ~ 2343 USD in Sweden. The lowest price in the Polish
area has a vaginal delivery payment rate of up to 5 times the INA-
CBGs claim for vaginal delivery in Indonesia.14
In addition, Nugraheni’s report from the Ministry of the Health
Republic of Indonesia shows the impact of the national health
insurance program on a significant reduction in vaginal delivery
cost.21 As is well known, financial problems, particularly in poor
people, will give harmful conditions for health status.22 The high
expense on health service costs will surely have an impact on the
family’s finances.23 Nevertheless, on the one hand, health insur-
ance must strive for high-quality health services for everyone not
excluded. The low price of vaginal delivery claims needs to be a
concerning issue. It is crucial to define a grouping algorithm as
Diagnosis-Related Group (DRG), which we refer to as INA-CBGs,
to have a fair performance comparison and hospital reimburse-
ment.24 The optimal design of the DRG system for labour cases is
critical to ensure adequate performance comparisons and appropri-
ate reimbursement for these causes of frequent hospitalizations.14
The impact of low financing can certainly disrupt service quality
and hospital cash flow, which needs to be further investigated.
Although the study did not investigate the correlation in
Caesarean Section (CS) rate, low vaginal financing could also be
associated with an increase in CS rate. The CS rate report from one
of the referral hospitals in the territory of Indonesia also shows an
SC rate of up to 50.2% for patients using the national health insur-
ance program (JKN).25 Furthermore, several comprehensive
national reports from BPJS Kesehatan also state that the CS rate
rose around 57% in 2017.8,26,27 Research shows that CS rates
above 10% are not associated with a reduction in maternal and
infant mortality. However, the WHO has never recommended a
specific rate in a country or hospital because each region has dif-
ferent particular situations. FIGO (The International Federation of
Gynecology and Obstetrics) gives one of the recommendations to
reduce unnecessary CS, including similarity cost both CS and
vaginal delivery for medical workers.28-30 Indeed, this is difficult
to do in Indonesia, where INA-CBGs financing claims for a vagi-
nal delivery are still deficient. The limitation of this study is that
the investigation was conducted only in one hospital. We need
more hospitals to compare hospital cost rates, even though in gen-
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Table 2. Comparison of total hospital costs and INA-CBGs cost in vaginal delivery.
Variable                        Total hospital cost (Rp.)                                INA-CBGs cost (Rp.)                                                       p
Vaginal deliveries                        9,238,022±1,265,801.88                                                 1,881,521.48±12,830.15                                                                    <0.001
Table 3. Analysis of severity level in vaginal delivery.
Variables              Severity level                                                                                   p
                                                  Level I n=30 (20.13%)                   Level II n=119 (79.87%)                                             
LOS (days)                                                             2.27±0.11                                                          3.03±0.09                                                                     <0.001
Total hospital cost (Rp)                         8,553,419.23±136,700.74                                9,410,611.04±150,834.49                                                         <0.001
INA-CBGs cost (Rp)                                 1,675,983.33±34,722.56                                   1,933,337.82±8,414.54                                                           <0.001
Cost disparity                                            -6,877,435.9±134,659.07                                 -7,477,273.2±151,189.09                                                           0.009









eral if we look at the claims of INA-CBGs from the government it
is much lower than in other countries. Increasing vaginal delivery
costs is a critical need to increase according to the actuarial level.
So the financing scheme in the national health insurance system
can support in providing high-quality maternal services and reduce
maternal and infant mortality rates in Indonesia.
Conclusion
The cost of vaginal delivery from the National Health
Insurance System is below the actuarial value. There is a reason-
ably high disparity, where bundling financing from the Indonesian
government in the form of INA-CBGs is lower than the total hos-
pital costs. As the severity increases, the patient’s LOS will be
longer, followed by a higher total hospital cost and a more signifi-
cant disparity in financing compared to the government’s INA-
CBGs package. So, from these findings it is assumed that the gov-
ernment can review policies and improve the system for the cost of
services for vaginal delivery to improve the quality of maternal
services, control the caesarean section rate, and reduce the mater-
nal mortality rate.
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